Diagnostics

DiagnosTear Announces Interim Clinical Study Results Demonstrating Excellent Correlation Between TeaRx(TM) Red Eye and Quantitative ELISA Testing

Vancouver, British Columbia--(Newsfile Corp. - July 9, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"),...

TempraMed Expands Institutional Healthcare Network with Meuhedet Health Services, a Leading HMO in Israel, Covering over 1 Million Lives

Acceptance of TempraMed's products by Meuhedet Health Services strengthens TempraMed's B2B institutional commercialization strategy as the Company advances reimbursement initiatives...

Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026

Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo's technologies, including—for the first time—an application of FAI-Score on...

Home Sleep Apnea Testing Market to Reach USD 996.6 Million by 2036, Driven by Expanding Telehealth Adoption and Rising Demand for Portable Sleep Diagnostics

NEWARK, Del., July 8, 2026 /PRNewswire/ -- According to Future Market Insights (FMI), the global home sleep apnea testing market is projected...

error: Content is protected !!